Moderna (MRNA) EBITDA Margin (QoQ) (2018 - 2026)
Moderna (MRNA) EBITDA Margin (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Moderna | 22.52 Bn | 17.32 Bn | -566.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23,041.00 |
| Dec 31, 2025 | -10,081.00 |
| Sep 30, 2025 | 61,314.00 |
| Jun 30, 2025 | 33,349.00 |
| Mar 31, 2025 | -84,324.00 |
| Dec 31, 2024 | -12,523.00 |
| Sep 30, 2024 | 56,180.00 |
| Jun 30, 2024 | 19,252.00 |
| Mar 31, 2024 | -75,830.00 |
| Dec 31, 2023 | 11,010.00 |
| Sep 30, 2023 | 43,285.00 |
| Jun 30, 2023 | -52,308.00 |
| Mar 31, 2023 | -5,073.00 |
| Dec 31, 2022 | -358.00 |
| Sep 30, 2022 | -1,687.00 |
| Jun 30, 2022 | -1,816.00 |
| Mar 31, 2022 | -534.00 |
| Dec 31, 2021 | 342.00 |
| Sep 30, 2021 | 128.00 |
| Jun 30, 2021 | 497.00 |